$4.290
+0.061 (+1.42%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SPRY por análisis de gráficos similares
Alphio's SPRY stock price prediction model matches the current ARS Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.29 (-0.03%). The 1-week path is $4.26 (-0.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de ARS Pharmaceuticals Inc?
ARS Pharmaceuticals Inc is not a good buy right now due to its current price of $4.02 being significantly lower than the analyst price targets of $15 and $30, indicating potential upside. However, the stock has a low RSI of 39.167, suggesting it may be oversold, but the recent 65.01% year-to-date decline raises concerns about its stability.
SPRY cerró en $4.29 el Tuesday, tras subir +1.42%
ARS Pharmaceuticals Inc (SPRY) last closed at $4.29, gaining +1.42%. These facts feed the 1-day and 1-week SPRY price prediction above.
Factores de la previsión
Los factores de la previsión de ARS Pharmaceuticals Inc (SPRY) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SPRY, ordenadas por similitud.
Análisis de estacionalidad de SPRY
Historically the probability of a positive October return for SPRY is 45.90%. May offers the highest probability of a positive month at 68.25%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SPRY
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $44.41 | $48.27 | $49.95 | +1025.14% |
| Nov 2026 | $21.36 | $33.41 | $45.12 | +678.74% |
| Dec 2026 | $33.53 | $48.27 | $57.15 | +1025.14% |
En 2026, se proyecta que ARS Pharmaceuticals Inc (SPRY) oscile entre $21.36 y $57.15.
Previsión mensual de ARS Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $48.27, con un mínimo de $44.41 y un máximo de $49.95.
En Nov de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $33.41, con un mínimo de $21.36 y un máximo de $45.12.
En Dec de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $48.27, con un mínimo de $33.53 y un máximo de $57.15.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.